SHBG and tauopathy: Our previous unbiased proteomics study revealed lower levels of sex hormone-binding globulin (SHBG) in the CSF of FTLD-Tau cases compared to FTLD-TDP or non-demented controls [4], suggesting that SHGB could be a potential biomarker for FTLD related tauopathies.